Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Statistics

Total Valuation

TSX:CTX has a market cap or net worth of CAD 13.96 million. The enterprise value is 5.71 million.

Market Cap	13.96M
Enterprise Value	5.71M

Important Dates

The next estimated earnings date is Friday, May 8, 2026.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:CTX has 18.61 million shares outstanding. The number of shares has decreased by -2.61% in one year.

Current Share Class	18.61M
Shares Outstanding	18.61M
Shares Change (YoY)	-2.61%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	13.48%
Owned by Institutions (%)	n/a
Float	16.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.66
PB Ratio	0.90
P/TBV Ratio	0.99
P/FCF Ratio	n/a
P/OCF Ratio	13.01
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.73, with an EV/FCF ratio of -163.27.

EV / Earnings	-62.11
EV / Sales	0.27
EV / EBITDA	12.73
EV / EBIT	n/a
EV / FCF	-163.27

Financial Position

The company has a current ratio of 3.33, with a Debt / Equity ratio of 0.02.

Current Ratio	3.33
Quick Ratio	2.27
Debt / Equity	0.02
Debt / EBITDA	0.70
Debt / FCF	-9.54
Interest Coverage	-24.33

Financial Efficiency

Return on equity (ROE) is -0.59% and return on invested capital (ROIC) is -12.97%.

Return on Equity (ROE)	-0.59%
Return on Assets (ROA)	-3.03%
Return on Invested Capital (ROIC)	-12.97%
Return on Capital Employed (ROCE)	-6.55%
Weighted Average Cost of Capital (WACC)	3.63%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.00
Inventory Turnover	2.28

Taxes

In the past 12 months, TSX:CTX has paid 9,000 in taxes.

Income Tax	9,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.51% in the last 52 weeks. The beta is -0.14, so TSX:CTX's price volatility has been lower than the market average.

Beta (5Y)	-0.14
52-Week Price Change	+41.51%
50-Day Moving Average	0.58
200-Day Moving Average	0.52
Relative Strength Index (RSI)	79.21
Average Volume (20 Days)	86,497

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CTX had revenue of CAD 21.12 million and -92,000 in losses. Loss per share was -0.00.

Revenue	21.12M
Gross Profit	11.11M
Operating Income	-1.02M
Pretax Income	-83,000
Net Income	-92,000
EBITDA	44,000
EBIT	-1.02M
Loss Per Share	-0.00

Balance Sheet

The company has 8.58 million in cash and 334,000 in debt, with a net cash position of 8.25 million or 0.44 per share.

Cash & Cash Equivalents	8.58M
Total Debt	334,000
Net Cash	8.25M
Net Cash Per Share	0.44
Equity (Book Value)	15.58M
Book Value Per Share	0.84
Working Capital	11.00M

Cash Flow

In the last 12 months, operating cash flow was 1.07 million and capital expenditures -1.11 million, giving a free cash flow of -35,000.

Operating Cash Flow	1.07M
Capital Expenditures	-1.11M
Depreciation & Amortization	1.50M
Net Borrowing	-515,000
Free Cash Flow	-35,000
FCF Per Share	-0.00

Margins

Gross margin is 52.60%, with operating and profit margins of -4.84% and -0.44%.

Gross Margin	52.60%
Operating Margin	-4.84%
Pretax Margin	-0.39%
Profit Margin	-0.44%
EBITDA Margin	0.21%
EBIT Margin	-4.84%
FCF Margin	n/a

Dividends & Yields

TSX:CTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.61%
Shareholder Yield	2.61%
Earnings Yield	-0.66%
FCF Yield	-0.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:CTX has an Altman Z-Score of -0.39 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.39
Piotroski F-Score	3